Cargando…
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer
Several studies in the last few years have determined that, in contrast to the prevailing dogma that drug resistance is simply due to Darwinian evolution—the selection of mutant clones in response to drug treatment—non-genetic changes can also lead to drug resistance whereby tolerant, reversible phe...
Autores principales: | Kulkarni, Prakash, Mohanty, Atish, Ramisetty, Sravani, Duvivier, Herbert, Khan, Ajaz, Shrestha, Sagun, Tan, Tingting, Merla, Amartej, El-Hajjaoui, Michelle, Malhotra, Jyoti, Singhal, Sharad, Salgia, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668935/ https://www.ncbi.nlm.nih.gov/pubmed/38002269 http://dx.doi.org/10.3390/biom13111587 |
Ejemplares similares
-
Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish
por: Singhal, Sharad S., et al.
Publicado: (2023) -
Addressing Drug Resistance in Cancer: A Team Medicine Approach
por: Kulkarni, Prakash, et al.
Publicado: (2022) -
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
por: Ramisetty, Sravani, et al.
Publicado: (2023) -
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors
por: Guo, Linlin, et al.
Publicado: (2023) -
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
por: Mohanty, Atish, et al.
Publicado: (2023)